跳至主要内容
临床试验/NCT02791399
NCT02791399已完成不适用

A Patient-Centered Intervention to Improve Opioid Safety

VA Office of Research and Development2 个研究点 分布在 1 个国家目标入组 286 人开始时间: 2016年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
286
试验地点
2
主要终点
Current Opioid Misuse Measure (COMM)

研究概览

简要总结

This is a randomized controlled trial of a multifaceted intervention designed to improve the safety of opioid prescribing. The specific aims of this study are to: (a) evaluate whether a multifaceted intervention (Improving the Safety of Opioid Prescribing; ISOP) enhances opioid safety, (b) assess whether participation in ISOP impacts the clinician-patient relationship, and (c) explore to what extent ISOP is associated with changes in pain and pain-related function.

详细描述

The investigators will randomize primary care providers (PCPs) at the VA Portland Health Care System to either ISOP or the control condition; patients will be nested by clinician status. All PCPs who enroll will participate in either a two-hour educational workshop or the two-hour educational workshop + nurse care manager (NCM). The NCM will maintain a registry of enrolled patients, track opioid medication-related events from the medical record, and provide decision support to PCPs for issues related to prescription opioid safety. The NCM will also meet individually with enrolled participants to discuss strategies for preventing/reducing opioid side effects, preventing diversion, and providing rationale for screening for prescription opioid misuse. The investigators will recruit patients who are already prescribed chronic opioid therapy for chronic non-cancer pain. Participants will be enrolled for one year. Outcomes will be measured at baseline, and 6 and 12 months after enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Enrollment in primary care at the VA Portland Health Care System
  • Receiving long-term opioid therapy (for at least 3 months) for chronic pain unrelated to a life-limiting disease
  • Able to read and write in English

排除标准

  • Age younger than 18 years old
  • On opioid therapy for palliative or end-of-life care
  • Current enrollment in an opioid substitution program
  • Lack of access to a telephone

结局指标

主要结局

Current Opioid Misuse Measure (COMM)

时间窗: Data collected at baseline, 6 months, and 12 months.

The Current Opioid Misuse Measure (COMM) is an assessment of self-reported risk of prescription opioid misuse. There are 17 items, each rated on a scale of 0 (never) to 4 (very often). Total scores range from 0 - 68, with higher scores indicating a greater risk of prescription opioid misuse.

Urine Drug Test

时间窗: Data collected at baseline, 6 months, and 12 months

Participants will complete urine drug tests (UDTs) to evaluate for presence of substances. UDTs will evaluate for cannabis, cocaine, amphetamines, benzodiazepines, barbiturates, opioids, and opiates. Study results are dichotomous.

次要结局

  • Chronic Pain Grade(One year)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验